VERBUND AG (VIE:VER)
Austria · Delayed Price · Currency is EUR 66.50
+0.60 (0.91%)
Aug 4, 2025, 5:37 PM CET
Marinus Pharmaceuticals Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 1,768 | 1,875 | 2,266 | 1,717 | 873.56 | 631.43 | Upgrade |
Depreciation & Amortization | 592.33 | 577.83 | 537.02 | 462.68 | 417.25 | 378.81 | Upgrade |
Loss (Gain) on Sale of Assets | 1.27 | 2.77 | 2.4 | 4.91 | -2.9 | 2.85 | Upgrade |
Loss (Gain) on Sale of Investments | 1.25 | -5.46 | -10.69 | 11.83 | -6.53 | -0.59 | Upgrade |
Loss (Gain) on Equity Investments | -20.21 | -18.71 | -48.56 | 17.26 | -29.39 | -19.77 | Upgrade |
Asset Writedown | -17.5 | 177.2 | 453.2 | 68.9 | -115.7 | -6.6 | Upgrade |
Change in Accounts Receivable | 76.95 | 165.75 | 357.03 | -192.27 | -1,068 | -10.96 | Upgrade |
Change in Inventory | 34.28 | -13.52 | 45.89 | -73.08 | -9.9 | 1.28 | Upgrade |
Change in Accounts Payable | 151.73 | -107.87 | 266.98 | 339.69 | 166.97 | 38.95 | Upgrade |
Change in Other Net Operating Assets | -180.95 | 263.25 | 815.82 | -570.61 | -262.87 | 92.3 | Upgrade |
Other Operating Activities | 329.74 | 332.04 | 397.75 | 233.53 | 135.89 | 74.44 | Upgrade |
Operating Cash Flow | 2,737 | 3,249 | 5,083 | 2,020 | 98.16 | 1,182 | Upgrade |
Operating Cash Flow Growth | -32.22% | -36.09% | 151.65% | 1957.68% | -91.70% | -1.84% | Upgrade |
Capital Expenditures | -1,184 | -1,138 | -1,399 | -1,091 | -854.04 | -602.36 | Upgrade |
Sale of Property, Plant & Equipment | 7.79 | 5.99 | 8.18 | 19.11 | 2.75 | 2.28 | Upgrade |
Cash Acquisitions | - | - | -11.67 | -478.52 | -247.2 | - | Upgrade |
Investment in Securities | -45.4 | -34.9 | -38.98 | -40.56 | -6.83 | 3.26 | Upgrade |
Other Investing Activities | - | - | 0 | 0 | -0 | - | Upgrade |
Investing Cash Flow | -1,222 | -1,166 | -1,441 | -1,591 | -1,105 | -596.81 | Upgrade |
Long-Term Debt Issued | - | 628.76 | 12.11 | 632.87 | 489.08 | - | Upgrade |
Long-Term Debt Repaid | - | -772.67 | -585.3 | -129.16 | -273.47 | -283.27 | Upgrade |
Net Debt Issued (Repaid) | -636.8 | -143.9 | -573.19 | 503.71 | 215.61 | -283.27 | Upgrade |
Common Dividends Paid | -1,329 | -1,934 | -1,554 | -477.83 | -260.56 | -239.72 | Upgrade |
Other Financing Activities | 195.91 | -173.2 | -960.41 | -363.85 | 1,321 | -57.78 | Upgrade |
Financing Cash Flow | -1,770 | -2,251 | -3,087 | -337.97 | 1,277 | -580.77 | Upgrade |
Miscellaneous Cash Flow Adjustments | -0.2 | - | - | - | 0 | -0 | Upgrade |
Net Cash Flow | -255.61 | -168.91 | 554.79 | 90.69 | 269.36 | 4.57 | Upgrade |
Free Cash Flow | 1,552 | 2,111 | 3,684 | 928.63 | -755.88 | 579.79 | Upgrade |
Free Cash Flow Growth | -38.71% | -42.70% | 296.76% | - | - | -28.70% | Upgrade |
Free Cash Flow Margin | 18.48% | 25.56% | 35.19% | 8.97% | -15.79% | 16.77% | Upgrade |
Free Cash Flow Per Share | 4.47 | 6.08 | 10.61 | 2.67 | -2.18 | 1.67 | Upgrade |
Cash Interest Paid | 53.2 | 39.1 | 62.5 | 36.1 | 17.9 | 28.5 | Upgrade |
Cash Income Tax Paid | 930.3 | 874.5 | 620.7 | 343.1 | 238.2 | 68.5 | Upgrade |
Levered Free Cash Flow | 1,228 | 1,365 | 1,727 | -440.91 | 814.19 | 599.97 | Upgrade |
Unlevered Free Cash Flow | 1,303 | 1,443 | 1,817 | -381.72 | 862.83 | 650.61 | Upgrade |
Change in Net Working Capital | -311.7 | -192.92 | -210.21 | 1,428 | -586.88 | -304.33 | Upgrade |
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.